INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,655 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
22
WD
Wendler DanielChief Accounting Officer
FLEXFLEX LTD.
Open-market sale
SELL$71K
488 sh
Jun 18, 2026Jun 22, 2026
Page 637 of 1717
← PrevNext →
traded Jun 18, 2026
+4d
SEC Form 4

Evidence

22
WJ
Wetterwald JulienChief Technology Officer
WLTHWEALTHFRONT CORP
Open-market sale · 10b5-1 plan
SELL$337K
39.8K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

22
WD
Wendler DanielChief Accounting Officer
FLEXFLEX LTD.
Open-market sale
SELL$117K
806 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

21
MT
Ming TracyFinancial Controller
IDAIT Stamp Inc
Grant or award
A—
2,669 sh
Jun 22, 2026Jun 22, 2026
traded Jun 22, 2026
+0dSEC Form 4

Evidence

21
PD
Poillon DianeDirector
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
1,000 sh
Jun 19, 2026Jun 22, 2026
traded Jun 19, 2026
+3dSEC Form 4

Evidence

21
HM
Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$2.13M
60.4K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

20
DH
Davis Cynthia HDirector
CIACITIZENS, INC.
Small acquisition
L$298
54 sh
May 5, 2026Jun 22, 2026
traded May 5, 2026
+48dSEC Form 4

Evidence

20
OV
Ossipow VincentDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$157K
28.8K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

20
CM
Cossery Jean-MichelDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$157K
28.8K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

20
HL
Hibbs Kathy LDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$108K
19.7K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

19
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise
M—
4,203 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
DH
Davis Cynthia HDirector
CIACITIZENS, INC.
Option exercise
M—
12.0K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
MD
Mounts Gonzales DavidDirector
EVLVEvolv Technologies Holdings, Inc.
Option exercise
M—
27.1K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
TM
Taylor MaryDirector
CIACITIZENS, INC.
Small acquisition
L$497
95 sh
May 29, 2026Jun 22, 2026
traded May 29, 2026
+24dSEC Form 4

Evidence

19
WA
Wong AliceDirector
HLHECLA MINING CO/DE/
Other acquisition or disposition
J$125K
14.4K sh
Jun 22, 2026Jun 22, 2026
traded Jun 22, 2026
+0dSEC Form 4

Evidence

19
DA
Dennis Phillip AndrewChief Medical Officer
NBPNovaBridge Biosciences
Option exercise
M—
10.3K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
DA
Dennis Phillip AndrewChief Medical Officer
NBPNovaBridge Biosciences
Option exercise
M—
23.7K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
TE
Toro Valencia Juan EstebanDirector
CIBGrupo Cibest S.A.
Grant or award
A$4,104
520 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
TH
Tan Kwang HooiChief Operating Officer
FLEXFLEX LTD.
Open-market sale
SELL$15K
100 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

19
ZN
Zapata Zuluaga NicolasDirector
CIBGrupo Cibest S.A.
Grant or award
A$4,139
524 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

19
WD
Wendler DanielChief Accounting Officer
FLEXFLEX LTD.
Open-market sale
SELL$2,487
17 sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

19
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Option exercise
M—
232 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
DM
Dawsey James MDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$14K
373 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
3,401 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$281K
4,582 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$335K
5,418 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
DO
Donnally James ODirector
INVInnventure, Inc.
Gift
G—
22.3K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
DO
Donnally James ODirector
INVInnventure, Inc.
Gift
G—
22.3K sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
DD
Duffy Kristine DDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$7,506
195 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

18
MC
Morris Philip CDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$7,506
195 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC Form 4

Evidence

17
RP
Raman PrakashDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A$13K
7,907 sh
Jun 19, 2026Jun 22, 2026
traded Jun 19, 2026
+3dSEC Form 4

Evidence

17
EH
Evans Jeffrey HerbertDirector
LCUTLIFETIME BRANDS, INC
Grant or award
A—
12.4K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

17
NH
Neubauer Caroll HDirector
BFLYButterfly Network, Inc.
Grant or award
A—
25.4K sh
Jun 22, 2026Jun 22, 2026
traded Jun 22, 2026
+0dSEC Form 4

Evidence

16
CT
Cox TroyDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$157K
28.8K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

16
HD
Hirsch DidierDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$108K
19.7K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

16
HL
Hibbs Kathy LDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$157K
28.8K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

16
CM
Cossery Jean-MichelDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$108K
19.7K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

16
CT
Cox TroyDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$108K
19.7K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

16
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Open-market sale · 10b5-1 plan
SELL$487K
43.1K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence

16
HD
Hirsch DidierDirector
SOPHSOPHiA GENETICS SA
Grant or award
A$157K
28.8K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC Form 4

Evidence